4Majumdar SR,Kjellstrand CM,Tymchak WJ,et al.Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography:a randomized controlled trial[J].Am J Kidney Dis,2009,54(4):602-609.
9Attallah N, Yassine L, Musial J, et al. The potential role of statins in contrast nephropathy. Clin Nephrol, 2004,62 : 273- 278.
10Khanal S,Attallah N, Smith DE, et al. Statin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventions. Am J Med, 2005,118:843-849.
1Devaraj S,Dasu MR,Jialal I.Diabetes is a proinflammatory state: a translational perspective[J].Expert Rev Endocrinol Metab,2010,5(l):19-28. PMID: 20204165.
2Gensini GF,Gori AM,Dilaghi B,et al.Effect of atorvastatin on circulating hsCRP concentrations: a sub-study of the achieve cholesterol targets fast with atorvastatin stratified titration (ACTFAST) study[J].Int J Cardiol,2010,142(3):257-6d. DOI: 10. 1016/j.ijcard.2008.12.213.
3Igoillo-Esteve M,Marselli L,Cunha DA,et al.Palmitate induces a pro-inflammatory response in human pancreatic islets thai mimics CCL2 expression by beta cells in type 2 diabetes[J].Diahetolog ia,2010,53(7): 1395-1405. DOI: 10.1007/s00125-010-1707-y.
4Boni-Schnetzler M,Thorne J,Parnaud G,et al.Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta -cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation[J].J Clin Endocrinol Metab,2008,93(10):4065-4074. DOI: 1 0.1210/jc.2008-0396.
5He L,He M,Lv X,et al.NF-kappaB binding activity and proinflammatory cytokines expression correlate with body mass index but not glycosylated hemoglobin in Chinese population[J].Diabetes Res Clin Pract,2010,90(1):73-80. DOI: 10.1016/j.diahres.2010.06.016.
6Abdin AA,Hassanien MA,lbrahim EA,et al.Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy[J].J Diabetes Complicatio ns,2010,24(5):325-333. DOI:10.1016/j.jdiacomp.2009.04.001.
7Sasaki J,Ikeda Y,Kuribayashi T,et at.A 52-week, randomized, openlabel, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levt,ls of low-density lipoprotein cholesterol and glucose intolerance[J].Clin Ther,2008,30(6):1089-1101. DOI: 10. 1016/j.clinthera.2008.05.017.
8Uemura Y,Watarai M,Ishii H,et al.Atorvastatin 10 mg plus ezetimibc 10mg compared with atorvastatin 20 mg: impact on the lipid profile in Japanese patients with abnormal glucose tolerance and coronary artery disease[J].J Cardiol,201,59(1):50-56. DOI: 10.1016/j.jjcc.2011.09.001.
